Skip to content

Magseed Magnetic Marker Localization

A Prospective, Open Label, Post Marketing Study of Magseed and Sentimag in Patients Undergoing Surgical Excision of a Breast Lesion That Requires Preoperative Radiographic Localization

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03020888
Enrollment
120
Registered
2017-01-13
Start date
2017-01-31
Completion date
2018-07-31
Last updated
2021-02-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Lesions, Disorders of Breast

Brief summary

The purpose of this post-marketing study is to provide prospective evidence that the Magseed and Sentimag® is effective for lesion localization in patients undergoing surgical excision of a breast lesion and to summarize measures of product safety and performance.

Detailed description

This is a post-market, prospective, open label, single arm study of Magseed and Sentimag in patients undergoing surgical excision of a breast lesion. Subjects will have the Magseed marker deployed under imaging guidance up to thirty days prior to surgery. The Magseed marker will be localized using the Sentimag system during surgery and removed with the lesion. After the lumpectomy procedure, subjects will be evaluated for safety and patient reported outcomes.

Interventions

DEVICEMagseed and Sentimag

Magseed marker and Sentimag probe for lesion localization

Sponsors

M.D. Anderson Cancer Center
CollaboratorOTHER
Endomagnetics Inc
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Subjects with a breast lesion requiring image-guided localization prior to excision. * Subjects aged 18 years or more at the time of consent.

Exclusion criteria

* The subject is pregnant or lactating. * Subject has pacemaker or other implantable device in the chest wall. * Subject has current active infection at the implantation site in the breast (per investigatordiscretion)

Design outcomes

Primary

MeasureTime frameDescription
Percent of Participants With Retrieval of Index Lesion and MagseedTime of surgery on average 16 minutesPercent retrieval rate of the index lesion and Magseed in the initial excised specimen. This is defined as the number of subjects in whom the index lesion and Magseed are retrieved in the initial excised specimen divided by the total number of subjects undergoing surgery.

Secondary

MeasureTime frameDescription
Percent of Participants With Radiological Ease of Placement Rated as Very Easy, or Fairly EasyAt the time of marker deployment on average 8.39 minutesRadiologist were asked to rate ease of marker placement graded from Very easy, Fairly Easy & Difficult after each marker placement.
Percentage of Markers With Radiological Placement Accuracy Measured as <5mm to LesionAt time of marker deployment on average 8.39 minutesSuccess rate of Magseed placement relative to the lesion (placement accuracy) measured as \<5mm to lesion; 5-10mm to lesion; \>10 mm to the target
Percentage of Participants With Re-excisionDuring surgery on average 16 minutesOverall re-excision rate and re-excision rate necessary to remove the Magseed or targeted lesion
Number of Device Related Adverse Events8 weeksRates of device-related adverse events and device-related serious adverse events
Surgical Localization - Duration of LocalizationAt time of surgery on average 16 minutesDuration of the lumpectomy procedure, time taken to remove the lesion
Percentage of Participants With Marker Retrieval Rated as Fairly or Very EasyOn the day of surgeryPathologist rated ease of marker identification and retrieval as: 1) Unable to retrieve 2) Difficult 3) Fairly difficult 4)fairly easy 5) very easy
Percent of Participants With Surgical Ease of Localization - Rated Fairly or Very EasyAt time of surgery on average 16 minutesSurgeon rated ease of localization during surgery assessed for each procedure as either very easy, fairly easy, fairly difficult, difficult, unable to localise

Countries

United States

Participant flow

Participants by arm

ArmCount
Magseed and Sentimag
Magseed marker deployed to mark a breast lesion under imaging guidance up to 30 days prior to surgery. Marker located during surgery using the Sentimag system, and removed with the lesion. Magseed and Sentimag: Magseed marker and Sentimag probe for lesion localization
107
Total107

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyInsurance coverage2
Overall StudyLost to Follow-up1
Overall StudyPhysician Decision4
Overall StudyWithdrawal by Subject6

Baseline characteristics

CharacteristicMagseed and Sentimag
Age, Continuous60.73 Years
STANDARD_DEVIATION 11.58
BMI28.83 kg/m^2
STANDARD_DEVIATION 5.91
Race and Ethnicity Not Collected— Participants
Sex: Female, Male
Female
107 Participants
Sex: Female, Male
Male
0 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 107
other
Total, other adverse events
0 / 107
serious
Total, serious adverse events
0 / 107

Outcome results

Primary

Percent of Participants With Retrieval of Index Lesion and Magseed

Percent retrieval rate of the index lesion and Magseed in the initial excised specimen. This is defined as the number of subjects in whom the index lesion and Magseed are retrieved in the initial excised specimen divided by the total number of subjects undergoing surgery.

Time frame: Time of surgery on average 16 minutes

ArmMeasureValue (NUMBER)
Magseed and SentimagPercent of Participants With Retrieval of Index Lesion and Magseed100 percentage of participants
Secondary

Number of Device Related Adverse Events

Rates of device-related adverse events and device-related serious adverse events

Time frame: 8 weeks

ArmMeasureValue (NUMBER)
Magseed and SentimagNumber of Device Related Adverse Events0 Number of device related adverse events
Secondary

Percentage of Markers With Radiological Placement Accuracy Measured as <5mm to Lesion

Success rate of Magseed placement relative to the lesion (placement accuracy) measured as \<5mm to lesion; 5-10mm to lesion; \>10 mm to the target

Time frame: At time of marker deployment on average 8.39 minutes

Population: 107 participants had 124 markers placed

ArmMeasureValue (NUMBER)
Magseed and SentimagPercentage of Markers With Radiological Placement Accuracy Measured as <5mm to Lesion95.16 percentage of markers
Secondary

Percentage of Participants With Marker Retrieval Rated as Fairly or Very Easy

Pathologist rated ease of marker identification and retrieval as: 1) Unable to retrieve 2) Difficult 3) Fairly difficult 4)fairly easy 5) very easy

Time frame: On the day of surgery

ArmMeasureValue (NUMBER)
Magseed and SentimagPercentage of Participants With Marker Retrieval Rated as Fairly or Very Easy96 percentage of participants
Secondary

Percentage of Participants With Re-excision

Overall re-excision rate and re-excision rate necessary to remove the Magseed or targeted lesion

Time frame: During surgery on average 16 minutes

Population: malignant breast lesions

ArmMeasureValue (NUMBER)
Magseed and SentimagPercentage of Participants With Re-excision9 percentage of participants
Secondary

Percent of Participants With Radiological Ease of Placement Rated as Very Easy, or Fairly Easy

Radiologist were asked to rate ease of marker placement graded from Very easy, Fairly Easy & Difficult after each marker placement.

Time frame: At the time of marker deployment on average 8.39 minutes

ArmMeasureValue (NUMBER)
Magseed and SentimagPercent of Participants With Radiological Ease of Placement Rated as Very Easy, or Fairly Easy98 % Participants
Secondary

Percent of Participants With Surgical Ease of Localization - Rated Fairly or Very Easy

Surgeon rated ease of localization during surgery assessed for each procedure as either very easy, fairly easy, fairly difficult, difficult, unable to localise

Time frame: At time of surgery on average 16 minutes

ArmMeasureValue (NUMBER)
Magseed and SentimagPercent of Participants With Surgical Ease of Localization - Rated Fairly or Very Easy86.9 percentage of participants
Secondary

Surgical Localization - Duration of Localization

Duration of the lumpectomy procedure, time taken to remove the lesion

Time frame: At time of surgery on average 16 minutes

ArmMeasureValue (MEAN)
Magseed and SentimagSurgical Localization - Duration of Localization5 minutes

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026